MacroGenics, Inc. To Present At The 26th Annual ROTH Conference

free biotech news Get the latest biotech news where you want it. Sign up for the free GenePool newsletter today!

ROCKVILLE, Md., March 3, 2014 (GLOBE NEWSWIRE) -- MacroGenics, Inc. (Nasdaq:MGNX), a clinical-stage biopharmaceutical company focused on discovering and developing innovative monoclonal antibody-based therapeutics for the treatment of cancer and autoimmune diseases, today announced that Jon Wigginton, M.D., Senior Vice President, Clinical Development and Jim Karrels, Vice President and Chief Financial Officer, of MacroGenics, are scheduled to present at the 26th Annual ROTH Conference on Monday, March 10, at 10:30 a.m. Pacific (1:30 p.m. Eastern Time).

Help employers find you! Check out all the jobs and post your resume.
MORE ON THIS TOPIC